Wei Su

2.1k total citations · 3 hit papers
57 papers, 1.4k citations indexed

About

Wei Su is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Wei Su has authored 57 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 36 papers in Molecular Biology, 16 papers in Pulmonary and Respiratory Medicine and 13 papers in Oncology. Recurrent topics in Wei Su's work include Ferroptosis and cancer prognosis (11 papers), Cancer-related molecular mechanisms research (7 papers) and Photosynthetic Processes and Mechanisms (7 papers). Wei Su is often cited by papers focused on Ferroptosis and cancer prognosis (11 papers), Cancer-related molecular mechanisms research (7 papers) and Photosynthetic Processes and Mechanisms (7 papers). Wei Su collaborates with scholars based in China, United States and Spain. Wei Su's co-authors include Ali Raza, Yan Lv, Xiling Zou, Muhammad Azhar Hussain, Sundas Saher Mehmood, Jiateng Zhong, Wen Xie, Yong Cheng, Tao Li and Manman Lu and has published in prestigious journals such as PLoS ONE, Cancer Research and Biochemical and Biophysical Research Communications.

In The Last Decade

Wei Su

55 papers receiving 1.4k citations

Hit Papers

Neoantigen: A New Breakthrough in Tumor Immunotherapy 2021 2026 2022 2024 2021 2023 2025 50 100 150 200

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Wei Su China 19 819 403 331 233 193 57 1.4k
Bin Han China 23 989 1.2× 455 1.1× 393 1.2× 156 0.7× 107 0.6× 52 1.8k
Wenguang Wu China 19 707 0.9× 278 0.7× 400 1.2× 301 1.3× 158 0.8× 42 1.4k
Rui Han China 17 541 0.7× 141 0.3× 234 0.7× 119 0.5× 103 0.5× 96 1.1k
Suthakar Ganapathy United States 19 1.1k 1.4× 145 0.4× 407 1.2× 370 1.6× 103 0.5× 60 1.7k
Xiang Zhu China 25 1.2k 1.4× 629 1.6× 515 1.6× 408 1.8× 387 2.0× 71 2.2k
Chao Zhou China 21 726 0.9× 132 0.3× 486 1.5× 131 0.6× 161 0.8× 54 1.2k
Wenyan Xiao China 15 890 1.1× 298 0.7× 253 0.8× 150 0.6× 198 1.0× 25 1.5k
Surendra K. Shukla United States 20 775 0.9× 93 0.2× 475 1.4× 360 1.5× 107 0.6× 43 1.4k
Guiying Shi China 20 793 1.0× 238 0.6× 197 0.6× 257 1.1× 45 0.2× 56 1.5k
Ju‐Ock Nam South Korea 19 883 1.1× 107 0.3× 223 0.7× 275 1.2× 109 0.6× 63 1.6k

Countries citing papers authored by Wei Su

Since Specialization
Citations

This map shows the geographic impact of Wei Su's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wei Su with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wei Su more than expected).

Fields of papers citing papers by Wei Su

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wei Su. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wei Su. The network helps show where Wei Su may publish in the future.

Co-authorship network of co-authors of Wei Su

This figure shows the co-authorship network connecting the top 25 collaborators of Wei Su. A scholar is included among the top collaborators of Wei Su based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wei Su. Wei Su is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Gao, Ying, Wenyu Di, Yuankai Shi, et al.. (2025). MFAP4 is a novel prognostic biomarker in glioma correlating with immunotherapy resistance and ferroptosis. Frontiers in Pharmacology. 16. 1551863–1551863. 4 indexed citations
2.
Raza, Ali, Savita Bhardwaj, Muhammad Anas, et al.. (2025). Role of plant peroxisomal catalase in temperature and drought stress: Physio-biochemical and molecular perspectives. Plant Physiology and Biochemistry. 229(Pt D). 110730–110730.
3.
Zhang, Yu, Wei Su, Zhou Yang, et al.. (2024). iPLA2β regulates the dual effects of arachidonic acid in thyroid cancer. Head & Neck. 47(2). 504–516. 1 indexed citations
4.
Liu, Mingjie, Yun Liu, Xiwen Xiong, et al.. (2024). The modification role and tumor association with a methyltransferase: KMT2C. Frontiers in Immunology. 15. 1444923–1444923. 3 indexed citations
5.
Cui, Kai, et al.. (2024). Advance in the role of chemokines/chemokine receptors in carcinogenesis: Focus on pancreatic cancer. European Journal of Pharmacology. 967. 176357–176357. 24 indexed citations
6.
Wang, Yan, et al.. (2023). A study on the level of NLRP3 inflammasome in patients with premature rupture of membranes. Immunity Inflammation and Disease. 11(9). e1018–e1018. 2 indexed citations
7.
Hong, Ting, et al.. (2022). Aging-related features predict prognosis and immunotherapy efficacy in hepatocellular carcinoma. Frontiers in Immunology. 13. 951459–951459. 7 indexed citations
8.
Song, Na, Jia Liu, Ke Zhang, et al.. (2022). The LIM Protein AJUBA is a Potential Oncogenic Target and Prognostic Marker in Human Cancer via Pan-Cancer Analysis. Frontiers in Cell and Developmental Biology. 10. 921897–921897. 2 indexed citations
9.
Chen, Yuhong, Zhihui Dou, Xiaohua Chen, et al.. (2022). Overexpression of splicing factor poly(rC)-binding protein 1 elicits cycle arrest, apoptosis induction, and p73 splicing in human cervical carcinoma cells. Journal of Cancer Research and Clinical Oncology. 148(12). 3475–3484. 6 indexed citations
10.
Hu, Xiaoge, Wenbin Fu, Wen Sun, et al.. (2022). The Emerging Role of RNA N6-Methyladenosine Modification in Pancreatic Cancer. Frontiers in Oncology. 12. 927640–927640. 5 indexed citations
11.
Raza, Ali, Wei Su, Dan Luo, et al.. (2022). Mechanistic Insights Into Trehalose-Mediated Cold Stress Tolerance in Rapeseed (Brassica napus L.) Seedlings. Frontiers in Plant Science. 13. 857980–857980. 43 indexed citations
12.
Raza, Ali, Ali Razzaq, Sundas Saher Mehmood, et al.. (2021). Omics: The way forward to enhance abiotic stress tolerance inBrassica napusL. GM crops & food. 12(1). 251–281. 55 indexed citations
14.
Zhang, Zheying, Huifang Zhu, Qian Li, et al.. (2021). Gene Expression Profiling of Tricarboxylic Acid Cycle and One Carbon Metabolism Related Genes for Prognostic Risk Signature of Colon Carcinoma. Frontiers in Genetics. 12. 647152–647152. 12 indexed citations
15.
Zhang, Jinghang, Dan Zang, Yun Xue, et al.. (2020). Gender Differences of NLRP1 Inflammasome in Mouse Model of Alzheimer's Disease. Frontiers in Aging Neuroscience. 12. 512097–512097. 12 indexed citations
16.
Wang, Haijun, Jia Liu, Jinsong Li, et al.. (2020). Identification of gene modules and hub genes in colon adenocarcinoma associated with pathological stage based on WGCNA analysis. Cancer Genetics. 242. 1–7. 34 indexed citations
17.
Su, Wei, Xiangdong Tian, Peng Liu, Dejun Zhou, & Fuliang Cao. (2020). Accuracy of endoscopic ultrasound-guided needle aspiration specimens for molecular diagnosis of non-small-cell lung carcinoma. World Journal of Clinical Cases. 8(21). 5139–5148. 2 indexed citations
18.
Xie, Wen, et al.. (2019). Synovial Fluid MicroRNA-210 as a Potential Biomarker for Early Prediction of Osteoarthritis. BioMed Research International. 2019. 1–4. 23 indexed citations
19.
Song, Weiwu, Mi Wang, Wei Su, et al.. (2017). Genetic and phenotypic effects of chromosome segments introgressed from Gossypium barbadense into Gossypium hirsutum. PLoS ONE. 12(9). e0184882–e0184882. 16 indexed citations
20.
Xie, Wen, et al.. (2017). SSeCKS/AKAP12 induces repulsion between human prostate cancer and microvessel endothelial cells through the activation of Semaphorin 3F. Biochemical and Biophysical Research Communications. 490(4). 1394–1398. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026